Influenza Vaccination for the Prevention of Cardiovascular Disease in the Americas: Consensus document of the Inter-American Society of Cardiology and the Word Heart Federation.

Álvaro Sosa Liprandi, María Inés Sosa Liprandi, Ezequiel José Zaidel, Gabriel M Aisenberg, Adrián Baranchuk, Eduardo Costa Duarte Barbosa, Gabriela Borrayo Sánchez, Bryce Alexander, Fernando Tomás Lanas Zanetti, Ricardo López Santi, Ana Girleza Múnera-Echeverri, Pablo Perel, Daniel Piskorz, Carlos Enrique Ruiz-Mori, Jorge Saucedo, Osiris Valdez, José Ramón González Juanatey, Daniel José Piñeiro, Fausto J Pinto, Fernando Stuardo Wyss Quintana
Author Information
  1. Álvaro Sosa Liprandi: School of Medicine, University of Buenos Aires, AR. ORCID
  2. María Inés Sosa Liprandi: Cardiology Department, Sanatorio Güemes, Buenos Aires, AR.
  3. Ezequiel José Zaidel: Cardiology Department, Sanatorio Güemes, Buenos Aires, AR. ORCID
  4. Gabriel M Aisenberg: University of Texas John P and Kathrine G McGovern School of Medicine, Houston, Texas, US. ORCID
  5. Adrián Baranchuk: Division of Cardiology, Kingston Health Science Center, Queen's University, Kingston, Ontario, CA. ORCID
  6. Eduardo Costa Duarte Barbosa: Cardiology Department, Hospital Sao Francisco-Santa Casa, Porto Alegre, BR. ORCID
  7. Gabriela Borrayo Sánchez: Cardiology Department, Mexican Social Security Institute, Mexican National Association of Cardiologists, MX. ORCID
  8. Bryce Alexander: Division of Cardiology, Kingston Health Science Center, Queen's University, Kingston, Ontario, CA. ORCID
  9. Fernando Tomás Lanas Zanetti: Cardiology Department, CIGES, Universidad de La Frontera, Temuco, CL. ORCID
  10. Ricardo López Santi: Cardiology Department, Hospital Italiano de La Plata, Buenos Aires, AR. ORCID
  11. Ana Girleza Múnera-Echeverri: Cardiology Department, Hospital General Medellin Luz Castro de Gutierrez E.S.E. Medellin, CO. ORCID
  12. Pablo Perel: Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, GB.
  13. Daniel Piskorz: Argentine Federation of Cardiology, AR. ORCID
  14. Carlos Enrique Ruiz-Mori: Cardiology Department, INEN, Lima, PE. ORCID
  15. Jorge Saucedo: Cardiology Department, Froedtert Hospital and Medical College, Milwaukee, US.
  16. Osiris Valdez: Cardiology Department, Centro Médico Central Romana, La Romana, DO.
  17. José Ramón González Juanatey: Cardiology Department, Hospital Clínico Universitario de Santiago de Compostela, Spanish Society of Cardiology, ES. ORCID
  18. Daniel José Piñeiro: World Heart Federation, Geneva, CH.
  19. Fausto J Pinto: World Heart Federation, Geneva, CH. ORCID
  20. Fernando Stuardo Wyss Quintana: InterAmerican Society of Cardiology, AR. ORCID

Abstract

Background: Cardiovascular mortality is decreasing but remains the leading cause of death world-wide. Respiratory infections such as influenza significantly contribute to morbidity and mortality in patients with cardiovascular disease. Despite of proven benefits, influenza vaccination is not fully implemented, especially in Latin America.
Objective: The aim was to develop a regional consensus with recommendations regarding influenza vaccination and cardiovascular disease.
Methods: A multidisciplinary team composed by experts in the management and prevention of cardiovascular disease from the Americas, convened by the Inter-American Society of Cardiology (IASC) and the World Heart Federation (WHF), participated in the process and the formulation of statements. The modified RAND/UCLA methodology was used. This document was supported by a grant from the WHF.
Results: An extensive literature search was divided into seven questions, and a total of 23 conclusions and 29 recommendations were achieved. There was no disagreement among experts in the conclusions or recommendations.
Conclusions: There is a strong correlation between influenza and cardiovascular events. Influenza vaccination is not only safe and a proven strategy to reduce cardiovascular events, but it is also cost saving. We found several barriers for its global implementation and potential strategies to overcome them.

Keywords

References

  1. Eur Heart J. 2008 Jan;29(1):96-103 [PMID: 18063596]
  2. Hum Vaccin Immunother. 2017 Jan 2;13(1):81-89 [PMID: 27624648]
  3. N Engl J Med. 2014 Aug 14;371(7):635-45 [PMID: 25119609]
  4. J Infect Dis. 2008 Mar 1;197(5):667-75 [PMID: 18260764]
  5. Hum Vaccin Immunother. 2017 Apr 3;13(4):877-888 [PMID: 28118092]
  6. Am Heart J. 2014 Nov;168(5):713-20 [PMID: 25440800]
  7. J Infect Dis. 2018 Feb 14;217(5):731-741 [PMID: 29220496]
  8. Vaccine. 2012 Aug 31;30(40):5893-900 [PMID: 22835738]
  9. BMC Public Health. 2019 Oct 23;19(1):1348 [PMID: 31640660]
  10. Vaccine. 2018 Jun 27;36(28):3993-3997 [PMID: 29866617]
  11. N Engl J Med. 1994 Sep 22;331(12):778-84 [PMID: 8065407]
  12. MMWR Morb Mortal Wkly Rep. 2009 Jul 17;58(27):749-52 [PMID: 19609249]
  13. Expert Rev Vaccines. 2018 Aug;17(8):687-696 [PMID: 30092690]
  14. Lancet Infect Dis. 2013 Jun;13(6):485-96 [PMID: 23518156]
  15. Vaccine. 2020 Jul 22;38(34):5498-5506 [PMID: 32593606]
  16. Vaccine. 2020 Sep 11;38(40):6236-6247 [PMID: 32792251]
  17. Isr J Med Sci. 1993 Dec;29(12):764-9 [PMID: 8300383]
  18. Hong Kong Med J. 2009 Oct;15 Suppl 6:44-7 [PMID: 19801718]
  19. Nat Rev Cardiol. 2011 Jan;8(1):30-41 [PMID: 21060326]
  20. Int J Clin Pract. 2015 Sep;69(9):928-37 [PMID: 25940136]
  21. Vaccine. 2013 Dec 9;31(51):6122-8 [PMID: 23933368]
  22. Heart. 2005 Dec;91(12):1601-2 [PMID: 16287745]
  23. BMC Med. 2017 Sep 8;15(1):166 [PMID: 28882149]
  24. Am J Med Qual. 1997 Fall;12(3):143-50 [PMID: 9287452]
  25. Am Heart J. 2019 Jun;212:36-44 [PMID: 30933856]
  26. MMWR Morb Mortal Wkly Rep. 1999 Oct 8;48(39):886-90 [PMID: 10550040]
  27. N Engl J Med. 2018 Jan 25;378(4):345-353 [PMID: 29365305]
  28. PLoS One. 2014 Jun 06;9(6):e98437 [PMID: 24905235]
  29. Influenza Other Respir Viruses. 2013 Jul;7(4):584-603 [PMID: 22974174]
  30. MMWR Morb Mortal Wkly Rep. 2015 Aug 7;64(30):818-25 [PMID: 26247435]
  31. Vaccine. 2021 Mar 15;39 Suppl 1:A42-A50 [PMID: 33518466]
  32. Clin Drug Investig. 2020 Sep;40(9):883-889 [PMID: 32696320]
  33. Vaccine. 2020 Jul 6;38(32):5002-5008 [PMID: 32532543]
  34. J Am Coll Cardiol. 1998 May;31(6):1226-33 [PMID: 9581712]
  35. Proc R Soc Med. 1965 May;58:295-300 [PMID: 14283879]
  36. Vaccine. 2007 Sep 28;25(39-40):6900-10 [PMID: 17764790]
  37. Vaccines (Basel). 2020 Mar 27;8(2): [PMID: 32230964]
  38. Influenza Other Respir Viruses. 2014 May;8(3):339-46 [PMID: 24895698]
  39. MMWR Recomm Rep. 2020 Aug 21;69(8):1-24 [PMID: 32820746]
  40. Vaccine. 2010 Dec 6;28(52):8268-74 [PMID: 20969925]
  41. J Clin Pharm Ther. 2012 Oct;37(5):505-9 [PMID: 22449298]
  42. Vaccine. 2001 Sep 14;19(32):4760-7 [PMID: 11535327]
  43. BMJ. 2009 Sep 15;339:b3680 [PMID: 19755545]
  44. Zhonghua Yu Fang Yi Xue Za Zhi. 2019 Oct 6;53(10):1000-1006 [PMID: 31607045]
  45. Am J Prev Med. 2006 Jul;31(1):72-9 [PMID: 16777545]
  46. Clin Infect Dis. 2010 Jan 15;50(2):175-83 [PMID: 20014948]
  47. JAMA. 2021 Jan 5;325(1):33-35 [PMID: 33275140]
  48. Aust N Z J Public Health. 2011 Apr;35(2):180-6 [PMID: 21463417]
  49. Medicina (B Aires). 2018;78(2):76-82 [PMID: 29659355]
  50. J Allergy Clin Immunol. 2016 Mar;137(3):868-78 [PMID: 26452420]
  51. Clin Infect Dis. 2011 Jan 15;52(2):e14-7 [PMID: 21288835]
  52. Am J Epidemiol. 2004 Sep 1;160(5):492-502 [PMID: 15321847]
  53. Viral Immunol. 2017 Jul/Aug;30(6):451-462 [PMID: 28650274]
  54. Lancet Infect Dis. 2010 Feb;10(2):83-92 [PMID: 20113977]
  55. J Intern Med. 1989 May;225(5):293-6 [PMID: 2732669]
  56. Vaccine. 2017 May 15;35(21):2775-2780 [PMID: 28431815]
  57. J Med Assoc Thai. 2014 Dec;97(12):1281-9 [PMID: 25764635]
  58. Risk Anal. 2014 Apr;34(4):735-50 [PMID: 24117921]
  59. J Infect Dis. 2011 Jun 15;203(12):1701-4 [PMID: 21606526]
  60. Lancet Infect Dis. 2009 Oct;9(10):601-10 [PMID: 19778762]
  61. Euro Surveill. 2015 Jun 18;20(24): [PMID: 26111238]
  62. Pharmacoeconomics. 2016 Sep;34(9):939-51 [PMID: 27423657]
  63. Ann Intern Med. 2020 Oct 20;173(8):597-604 [PMID: 32866418]
  64. Can Fam Physician. 2001 Nov;47:2261-6 [PMID: 11768924]
  65. BMC Infect Dis. 2014 Nov 25;14:618 [PMID: 25420713]
  66. Lancet. 2013 Apr 27;381(9876):1461-8 [PMID: 23498095]
  67. Drugs Aging. 2005;22(6):495-515 [PMID: 15974640]
  68. Vaccine. 2020 Apr 29;38(20):3682-3689 [PMID: 32249017]
  69. Vaccine. 2002 May 15;20 Suppl 2:S21-4 [PMID: 12110251]
  70. AIDS. 2013 Jan 2;27(1):87-93 [PMID: 23018437]
  71. PLoS One. 2019 Aug 9;14(8):e0220781 [PMID: 31398195]
  72. N Engl J Med. 2013 Dec 26;369(26):2564-6 [PMID: 24224560]
  73. Clin Pediatr (Phila). 1979 Jan;18(1):42-4 [PMID: 759059]
  74. Vaccine. 2014 Oct 21;32(46):6075-83 [PMID: 25239481]
  75. Neuroepidemiology. 2017;48(3-4):103-110 [PMID: 28628919]
  76. Eur Heart J. 2007 May;28(10):1205-10 [PMID: 17440221]
  77. Vaccine. 2000 Dec 8;19(9-10):1180-7 [PMID: 11137255]
  78. Vaccine. 2017 May 15;35(21):2811-2817 [PMID: 28427844]
  79. Can J Hosp Pharm. 2017 Jan-Feb;70(1):27-34 [PMID: 28348430]
  80. Am J Med. 2003 Jan;114(1):31-8 [PMID: 12543287]
  81. Kardiologiia. 2002;42(7):21-4 [PMID: 12494108]
  82. JACC Heart Fail. 2019 Feb;7(2):112-117 [PMID: 30611718]
  83. Vaccine. 2009 Oct 23;27(45):6284-90 [PMID: 19856521]
  84. JAMA. 2013 Oct 23;310(16):1711-20 [PMID: 24150467]
  85. Oncotarget. 2017 Nov 09;8(68):112697-112711 [PMID: 29348857]
  86. Vaccine. 2021 Mar 15;39 Suppl 1:A51-A55 [PMID: 32576459]
  87. N Engl J Med. 2019 Jan 10;380(2):171-176 [PMID: 30625066]
  88. Salud Publica Mex. 2005 May-Jun;47(3):234-9 [PMID: 16104466]
  89. Ann Intern Med. 1994 Dec 15;121(12):947-52 [PMID: 7978721]
  90. PLoS One. 2019 May 1;14(5):e0215978 [PMID: 31042752]
  91. Pediatr Infect Dis J. 2009 Jul;28(7):563-71 [PMID: 19561422]
  92. Ann Intern Med. 2020 Aug 18;173(4):253-261 [PMID: 32568572]
  93. N Engl J Med. 2003 Apr 3;348(14):1322-32 [PMID: 12672859]
  94. MMWR Recomm Rep. 2002 Apr 12;51(RR-3):1-31 [PMID: 12002171]
  95. Am J Infect Control. 2014 Jan;42(1):69-70 [PMID: 24176601]
  96. Vaccine. 2014 Jun 12;32(28):3480-7 [PMID: 24793951]
  97. Thromb Haemost. 2009 Dec;102(6):1259-64 [PMID: 19967159]
  98. Eur J Intern Med. 2015 Oct;26(8):596-8 [PMID: 26365372]
  99. Vaccine. 2020 Aug 18;38(37):5923-5926 [PMID: 32709434]
  100. J Am Geriatr Soc. 2016 Oct;64(10):2126-2131 [PMID: 27709600]
  101. Vaccine. 2006 Feb 13;24(7):1035-43 [PMID: 16183177]
  102. J Am Geriatr Soc. 2004 Jan;52(1):25-30 [PMID: 14687311]
  103. Eur Heart J. 2011 Jul;32(14):1730-5 [PMID: 21289042]
  104. MMWR Morb Mortal Wkly Rep. 1988 Nov 4;37(43):657-61 [PMID: 3141764]
  105. Eur Heart J. 2017 Feb 1;38(5):326-333 [PMID: 27660378]
  106. Vaccine. 2004 Dec 16;23(5):639-45 [PMID: 15542184]
  107. Value Health. 2007 Mar-Apr;10(2):98-116 [PMID: 17391419]
  108. Zhonghua Yu Fang Yi Xue Za Zhi. 2019 Oct 6;53(10):993-999 [PMID: 31607044]
  109. Vaccine. 2011 Nov 3;29(47):8696-704 [PMID: 21906647]
  110. PLoS One. 2019 Apr 29;14(4):e0213499 [PMID: 31034485]
  111. JACC Heart Fail. 2016 Feb;4(2):152-158 [PMID: 26746371]
  112. Expert Rev Vaccines. 2018 Jul;17(7):653-663 [PMID: 29961353]
  113. J Geriatr Cardiol. 2018 Jun;15(6):413-421 [PMID: 30108613]
  114. N Engl J Med. 2004 Feb 26;350(9):896-903 [PMID: 14985487]
  115. Hum Vaccin. 2005 Nov-Dec;1(6):217-23 [PMID: 17012866]
  116. Am J Med Sci. 2004 Mar;327(3):113-7 [PMID: 15090748]
  117. Cochrane Database Syst Rev. 2015 May 05;(5):CD005050 [PMID: 25940444]
  118. Vaccine. 2007 Aug 29;25(35):6511-21 [PMID: 17681651]
  119. Heart. 2020 Mar;106(5):350-357 [PMID: 31444266]
  120. Thromb J. 2007 Oct 16;5:16 [PMID: 17939867]
  121. Ann Allergy Asthma Immunol. 2012 Dec;109(6):426-30 [PMID: 23176882]
  122. Postgrad Med J. 2020 Jan;96(1131):4-6 [PMID: 31732511]
  123. Int J Environ Res Public Health. 2020 Apr 03;17(7): [PMID: 32260048]
  124. Pharmacoeconomics. 2018 Dec;36(12):1475-1490 [PMID: 30251078]
  125. PLoS One. 2016 Jun 20;11(6):e0157657 [PMID: 27322384]
  126. Am Heart J. 2017 Jul;189:94-102 [PMID: 28625387]
  127. Clin Microbiol Infect. 2020 Jan;26(1):101-106 [PMID: 31108229]
  128. JAMA. 2021 Jan 5;325(1):39-49 [PMID: 33275134]
  129. Circulation. 2019 Jan 29;139(5):575-586 [PMID: 30586760]
  130. Am J Cardiol. 1984 Feb 1;53(4):481-2 [PMID: 6695777]
  131. J Infect Dis. 2012 Sep 15;206(6):821-7 [PMID: 22798684]
  132. EBioMedicine. 2016 Oct;12:295-301 [PMID: 27658738]
  133. Arq Bras Cardiol. 2011 Mar;96(3):240-5 [PMID: 21271169]
  134. Vaccine. 2015 Jan 29;33(5):734-41 [PMID: 25444791]
  135. Eur J Pharm Biopharm. 2015 Aug;94:251-63 [PMID: 26047796]
  136. Int J Cardiol. 2019 Feb 15;277:1-2 [PMID: 30661544]
  137. BMC Med. 2015 Mar 17;13:53 [PMID: 25857236]
  138. Eur Heart J. 2008 Jun;29(11):1350-8 [PMID: 18187561]
  139. Hum Vaccin. 2006 May-Jun;2(3):110-2 [PMID: 17012908]
  140. Value Health. 2011 Sep-Oct;14(6):800-11 [PMID: 21914499]
  141. N Engl J Med. 2007 Oct 4;357(14):1373-81 [PMID: 17914038]
  142. Hum Vaccin Immunother. 2018 Jun 3;14(6):1331-1341 [PMID: 29425079]
  143. Medicina (B Aires). 2020;80(5):541-553 [PMID: 33048800]
  144. Psychiatry Clin Neurosci. 1997 Aug;51(4):181-4 [PMID: 9316161]
  145. Value Health. 2014 Nov;17(7):A678 [PMID: 27202501]
  146. JAMA Cardiol. 2019 Apr 1;4(4):363-369 [PMID: 30916717]
  147. Tex Heart Inst J. 2004;31(1):4-13 [PMID: 15061620]
  148. J Am Heart Assoc. 2021 Mar 16;10(6):e019636 [PMID: 33719496]
  149. Prev Med. 2019 Sep;126:105734 [PMID: 31152830]
  150. Clin Drug Investig. 2012 Feb 1;32(2):73-85 [PMID: 22201294]
  151. BMJ. 2015 Dec 08;351:h6291 [PMID: 26645895]
  152. Hum Vaccin Immunother. 2018 Mar 4;14(3):550-564 [PMID: 29232151]
  153. PLoS One. 2011;6(9):e24384 [PMID: 21915319]
  154. Eur Respir J. 2018 Mar 29;51(3): [PMID: 29563170]
  155. N Engl J Med. 1995 Oct 5;333(14):889-93 [PMID: 7666874]
  156. Vaccine. 2016 May 11;34(22):2507-12 [PMID: 27015735]
  157. Hum Vaccin Immunother. 2016 Aug 2;12(8):2206-2214 [PMID: 27196006]
  158. Sci Rep. 2020 Aug 31;10(1):14264 [PMID: 32868834]
  159. Vaccine. 2012 Aug 24;30(39):5761-9 [PMID: 22796139]
  160. PLoS One. 2011;6(11):e27420 [PMID: 22110645]
  161. Vaccine. 2008 Apr 16;26(17):2142-53 [PMID: 18343537]
  162. Vaccine. 2021 Mar 15;39 Suppl 1:A24-A35 [PMID: 33422382]
  163. Clin Exp Vaccine Res. 2017 Jan;6(1):38-44 [PMID: 28168172]
  164. Hum Vaccin Immunother. 2018;14(8):1867-1873 [PMID: 29708843]
  165. JAMA Cardiol. 2019 Nov 1;4(11):1102-1111 [PMID: 31479100]
  166. Hum Vaccin Immunother. 2016 Sep;12(9):2269-77 [PMID: 27184622]
  167. BMC Med. 2020 Apr 14;18(1):90 [PMID: 32284056]
  168. Vaccine. 2020 Jan 29;38(5):1057-1064 [PMID: 31787414]
  169. Vaccines (Basel). 2021 Feb 04;9(2): [PMID: 33557082]
  170. Eur Heart J. 2021 May 21;42(20):2015-2018 [PMID: 33748833]
  171. Circulation. 2002 May 7;105(18):2143-7 [PMID: 11994246]
  172. PLoS One. 2019 Sep 18;14(9):e0222178 [PMID: 31532789]
  173. Heart. 2016 Dec 15;102(24):1953-1956 [PMID: 27686519]
  174. J Am Coll Cardiol. 2019 Jun 25;73(24):3168-3209 [PMID: 30423391]
  175. Environ Res. 2017 Jul;156:688-696 [PMID: 28477579]
  176. Heart Rhythm. 2016 Jun;13(6):1189-94 [PMID: 26850784]
  177. Rev Salud Publica (Bogota). 2009 Oct;11(5):689-99 [PMID: 20339595]
  178. Vaccine. 2002 Jun 7;20(19-20):2494-9 [PMID: 12057604]
  179. Lancet. 1998 May 16;351(9114):1467-71 [PMID: 9605802]
  180. PLoS One. 2017 Jan 26;12(1):e0170550 [PMID: 28125629]
  181. Value Health. 2019 Dec;22(12):1345-1354 [PMID: 31806190]

MeSH Term

Cardiology
Cardiovascular Diseases
Consensus
Humans
Influenza, Human
Latin America
United States
Vaccination

Word Cloud

Created with Highcharts 10.0.0influenzacardiovasculardiseasevaccinationrecommendationsCardiovascularmortalityprovenconsensusexpertsInter-AmericanSocietyCardiologyHeartFederationWHFdocumentconclusionseventsInfluenzaBackground:decreasingremainsleadingcausedeathworld-wideRespiratoryinfectionssignificantlycontributemorbiditypatientsDespitebenefitsfullyimplementedespeciallyLatinAmericaObjective:aimdevelopregionalregardingMethods:multidisciplinaryteamcomposedmanagementpreventionAmericasconvenedIASCWorldparticipatedprocessformulationstatementsmodifiedRAND/UCLAmethodologyusedsupportedgrantResults:extensiveliteraturesearchdividedsevenquestionstotal2329achieveddisagreementamongConclusions:strongcorrelationsafestrategyreducealsocostsavingfoundseveralbarriersglobalimplementationpotentialstrategiesovercomethemVaccinationPreventionDiseaseAmericas:ConsensusWordmyocardialinfarction

Similar Articles

Cited By (8)